{
    "clinical_study": {
        "@rank": "107640", 
        "arm_group": [
            {
                "arm_group_label": "ketogenic diet", 
                "arm_group_type": "Active Comparator", 
                "description": "ketogenic diet (2.5 to 4:1)"
            }, 
            {
                "arm_group_label": "Modifid Atkin's diet", 
                "arm_group_type": "Active Comparator", 
                "description": "Modified Atkin's Diet"
            }
        ], 
        "brief_summary": {
            "textblock": "In children aged 1yr -18 years with refractory epilepsy Modified Atkins diet as add on to\n      ongoing AED therapy would not be inferior compared to ketogenic diet **  in terms of seizure\n      reduction from baseline seizure frequency at 6 months"
        }, 
        "brief_title": "Efficacy of Modified Atkins Diet Versus Ketogenic Diet in Children With Refractory Epilepsy Aged 1 Year to 18 Years: A Randomized Controlled Trial", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Ketogenic Diet, Modified Atkin's Diet, Refractory Epilepsy", 
        "condition_browse": {
            "mesh_term": "Epilepsy"
        }, 
        "detailed_description": {
            "textblock": "Primary objective:\n\n      To compare the efficacy of Modified Atkins diet compared to Ketogenic diet * in children\n      aged 1 year to 18 years of age with refractory epilepsy on anti epileptic drugs at 6 months\n      of diet intake  in terms of percentage of seizure reduction from base line.\n\n      Secondary objective:\n\n      Proportion of patients who achieve > 50% seizure reduction  from baseline after 6 months  in\n      both groups To evaluate the nature of adverse events in both the groups"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children aged 1-18 years with refractory epilepsy*\n\n          -  Willing to come for regular follow up\n\n          -  No motivational or psychosocial issues in the family which would preclude compliance\n             with the diet\n\n        Exclusion Criteria\n\n          -  Surgically remediable cause for refractory epilepsy\n\n          -  Suspected mitochondrial disorder or diagnosed with a disorder in which high fat diet\n             is contraindicated\n\n          -  Previously received ketogenic diet or modified Atkins diet\n\n          -  Chronic systemic disease like chronic kidney disease, chronic liver disease, heart\n             disease (congenital and acquired) and chronic respiratory illness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01983163", 
            "org_study_id": "9968480606"
        }, 
        "intervention": [
            {
                "arm_group_label": "ketogenic diet", 
                "intervention_name": "Ketogenic diet (2.5 to 4:1)", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Modifid Atkin's diet", 
                "intervention_name": "Modified Atkin's diet", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 7, 2013", 
        "location": {
            "contact": {
                "email": "sheffaligulati@gmail.com", 
                "last_name": "Sheffali Gulati, MD, Pediatrics", 
                "phone": "01126594679"
            }, 
            "facility": {
                "address": {
                    "city": "New Delhi", 
                    "country": "India", 
                    "state": "Delhi", 
                    "zip": "110029"
                }, 
                "name": "All India Institute of Medical Sciences"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "sheffaligulati@gmail.com", 
            "last_name": "Sheffali Gulati, MD Pediatrics", 
            "phone": "01126594679"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "India: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To develop  an optimal dietary therapy for management of refractory epilepsy in children and adolescents", 
            "measure": "Percentage of seizure reduction at 6 months ( sz frequency / wk average of 4 wks) from base line", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01983163"
        }, 
        "responsible_party": {
            "investigator_affiliation": "All India Institute of Medical Sciences, New Delhi", 
            "investigator_full_name": "Sheffali Gulati", 
            "investigator_title": "Addl. Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "All India Institute of Medical Sciences, New Delhi", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "All India Institute of Medical Sciences, New Delhi", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}